809 Phase 2 trial of neoadjuvant and adjuvant PD-1 checkpoint blockade in local-regionally advanced, resectable HNSCC indicates pathological response is associated with high disease-free survival

Bibliographic Details
Main Authors: Trisha Wise-Draper, Diana Bell, Roman Jandarov, Shuchi Gulati, Maura Gillison, Vinita Takiar, Sarah Palackdharry, Francis Worden, Matthew Old, John Kaczmar, Neal Dunlap, Benjamin Hinrichs, Yash Patil, Muhammad Kashif Riaz, Layne Weatherford, Aubrey Hamilton, Sheena Lanverman, Michelle Mierzwa, Keith Casper, Jonathan Mark, Alice Tang, Chad Zender, Ann Gillenwater, Mario Medvedovich, J Jack Lee
Format: Article
Language:English
Published: BMJ Publishing Group 2020-11-01
Series:Journal for ImmunoTherapy of Cancer